WKYMVM
Discontinued Product
Biological Activity
WKYMVM is a selective agonist for the formyl peptide receptors FPR2 and FPR3, expressed on immune cells. EC50 values for induction of calcium mobilization in FPR2-HL-60 cells and FPR3-HL-60 cells are 2 and 80 nM respectively.Technical Data
(Modifications: Met-6 = C-terminal amide)
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Background References
-
Neutrophil stunning by metoprolol reduces infarct size
J García-Pri, R Villena-Gu, M Gómez, E Bernardo, A Pun-García, I García-Lun, G Crainiciuc, R Fernández-, V Sreeramkum, R Bourio-Mar, JM García-Rui, AS Del Valle, D Sanz-Rosa, G Pizarro, A Fernández-, A Hidalgo, V Fuster, B Ibanez
Nat Commun, 2017;8(0):14780. -
Identification of the peptides that stimulate the phosphoinositide hydrolysis in lymphocyte cell lines from peptide libraries.
Baek et al.
J.Biol.Chem., 1996;271:8170 -
The synthetic peptide Trp-Lys-Tyr-Met-Val-Met-NH2 specifically activates neutrophils through FPRL1/Lipoxin A4 receptors and is an agonist for the orphan monocyte-expressed chemoattractant receptor FPRL2.
Christophe et al.
J.Biol.Chem., 2001;276:21585 -
Phagocyte activation by Trp-Lys-Tyr-Met-Val-Met, acting through FPRL1 /LXA4R, is not affected by lipoxin.
Christophe et al.
Scand.J.Immunol., 2002;56:470
Product Datasheets
Reconstitution Calculator
Molarity Calculator
Citations for WKYMVM
The citations listed below are publications that use Tocris products. Selected citations for WKYMVM include:
5 Citations: Showing 1 - 5
-
Neutrophils self-limit swarming to contain bacterial growth in vivo
Authors: Kienle Et al.
Science 2021;372
-
Neutrophil stunning by MP reduces infarct size.
Authors: García-Prieto Et al.
Nat Commun 2017;8:14780
-
Antagonism of human formyl peptide receptor 1 (FPR1) by chromones and related isoflavones.
Authors: Schepetkin Et al.
Biochem Pharmacol 2014;92:627
-
3-(1H-indol-3-yl)-2-[3-(4-nitrophenyl)ureido]propanamide enantiomers with human formyl-peptide receptor agonist activity: molecular modeling of chiral recognition by FPR2.
Authors: Schepetkin Et al.
Biochem Pharmacol 2013;85:404
-
Gastrin-releasing peptide/neuromedin B receptor antagonists PD176252, PD168368, and related analogs are potent agonists of human formyl-peptide receptors.
Authors: Schepetkin Et al.
Mol Pharmacol 2011;79:77
FAQs
No product specific FAQs exist for this product, however you may
View all Peptide FAQsReviews for WKYMVM
There are currently no reviews for this product. Be the first to review WKYMVM and earn rewards!
Have you used WKYMVM?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
